Pfizer Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $104.01B | $181.48B | $1.94B |
| FY2022 | $101.29B | $197.21B | $416.0M |
| FY2023 | $137.21B | $226.50B | $2.85B |
| FY2024 | $124.90B | $213.40B | $1.04B |
| FY2025 | $121.39B | $208.16B | $1.14B |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $104.01B | $181.48B | $1.94B |
| FY2022 | $101.29B | $197.21B | $416.0M |
| FY2023 | $137.21B | $226.50B | $2.85B |
| FY2024 | $124.90B | $213.40B | $1.04B |
| FY2025 | $121.39B | $208.16B | $1.14B |